ELVNYSEHospital & Medical Service PlansFiscal year ends December 31

Elevance Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026

$430.23+1.97 (+0.46%)

Close on Oct 19, 2026

Market cap: $93.75B
P/E (TTM): 19.1
Dividend yield: –

Elevance Health, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	199,125	177,011	171,340	156,595	138,639	121,867	104,213	92,105	90,040	84,863	79,157	73,874	71,024	61,497	60,711	58,699	64,940	61,251	61,168
Cost of Revenue	21,178	19,750	17,293	13,035	10,895	8,953	1,992	0	0	–	–	–	–	137	0	0	419	469	433
Gross Profit	177,947	157,261	154,047	143,560	127,744	112,914	102,221	92,105	90,040	–	–	–	–	61,360	60,711	58,699	64,521	60,783	60,735
Selling, General & Admin	20,984	20,025	20,087	17,700	15,918	17,450	13,364	14,020	12,650	12,559	12,535	11,748	9,953	8,681	8,436	8,733	9,019	8,497	8,702
General & Administrative	–	–	–	–	–	–	–	–	11,254	11,166	11,094	10,258	8,426	7,094	6,819	7,122	7,334	6,719	6,985
Advertising Expenses	395	540	599	511	588	558	467	385	338	246	314	337	351	285	288	226	310	216	–
Total Costs & Expenses	192,415	169,107	163,625	148,995	130,644	115,629	98,228	87,037	86,076	80,308	74,526	69,506	67,183	57,639	56,753	54,345	57,537	58,129	55,910
Operating Income	7,199	7,862	8,499	8,283	7,559	6,360	5,999	5,426	4,175	4,801	4,753	4,418	4,001	3,620	3,782	4,078	4,179	4,348	–
Interest Expense	1,402	1,185	1,030	851	798	784	746	753	739	723	653	601	603	512	430	419	447	470	448
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	769	706	728	–	–	–	–	–
Income from Equity Investments	398	1.00	-33	293	562	51	93	–	–	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	108	103	446	7.00	73	198	0	0	2.00	45	1.80	7.90	48	67	0	21	263	–	–
Gain (Loss) on Investments	–	–	–	–	-71	194	63	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0	201	0	0	–	–	-3.00	-13	-15	-5.00	-16	1.70	-3.90	-4.70	-3.30	-1.90	-16	-7.20	-11
Pretax Income	6,710	7,904	7,715	7,600	7,995	6,238	5,985	5,068	3,964	4,555	4,631	4,368	3,840	3,858	3,958	4,354	7,403	3,122	5,258
Income Tax Expense	1,049	1,933	1,724	1,712	1,846	1,666	1,178	1,318	121	2,085	2,071	1,808	1,206	1,207	1,311	1,467	2,657	632	1,913
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	2,470	2,560	2,560	2,634	2,651	2,647	–	–	–	–
Income from Discontinued Operations	–	–	–	–	–	–	–	–	–	0	0	9.60	-145	4.50	0	–	–	–	–
Net Income incl. Noncontrolling Interests	5,661	5,971	5,991	5,888	6,149	4,572	4,807	–	–	–	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	-1.00	-9.00	4.00	-6.00	-9.00	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	5,662	5,980	5,987	5,894	6,158	4,572	4,807	3,750	3,843	2,470	2,560	2,570	2,490	2,656	2,647	2,887	4,746	2,491	3,345
EPS (Basic)(per share)	25.28	25.81	25.38	24.56	25.26	18.23	18.81	14.53	14.70	9.39	9.73	9.31	8.34	8.26	7.35	7.03	9.96	4.79	5.64
EPS (Diluted)(per share)	25.21	25.68	25.22	24.28	24.95	17.98	18.47	14.19	14.35	9.21	9.38	8.99	8.20	8.18	7.25	6.94	9.88	4.76	5.56
Shares Outstanding (Basic, Weighted)(shares)	224	232	236	240	244	251	256	258	262	263	263	276	299	322	360	411	476	520	–
Shares Outstanding (Diluted, Weighted)(shares)	225	233	237	243	247	254	260	264	268	268	273	286	304	325	365	416	481	523	–
Dividend per Share(per share)	–	–	5.92	5.12	4.52	3.80	3.20	3.00	2.70	2.60	2.50	1.75	1.50	1.15	1.00	0.00	–	–	–
EBITDA	8,745	9,255	10,244	9,958	8,861	7,514	7,132	6,558	–	–	–	–	–	–	–	–	–	–	–
Premiums Earned	164,639	144,166	142,854	133,229	117,373	104,109	94,173	85,421	83,648	78,860	73,385	68,390	66,119	56,497	55,970	53,974	56,382	57,101	55,865
Net Investment Income	2,194	2,051	1,825	1,485	1,378	877	1,005	970	867	779	678	724	659	686	704	803	801	851	1,001
Policyholder Benefits & Claims	148,223	127,567	124,330	116,642	102,571	88,045	81,786	71,895	72,236	66,834	61,117	56,855	56,237	48,214	47,648	44,930	47,122	48,266	46,037

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 89.1%
Operating margin: 2.7%
Net margin: 2.5%
Return on equity, FY2025: 13.3%

Financial strength

Current ratio: 1.52
Debt to equity: 0.69
Debt to assets: 24.6%
Cash to current liabilities: 23.1%

Valuation

P/E ratio: 19.1
Price to sales: 0.47
Price to book: 2.09
Dividend yield: –